University of Illinois at Chicago
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Illinois at Chicago sits in the top decile of US sponsors by registered trial count (#83 of 15,742 sponsors by registered trial count).
University of Illinois at Chicago: 430 sponsored US clinical trials, 115 recruiting.
University of Illinois at Chicago sponsors 430 registered US clinical trials on ClinicalTrials.gov, 115 of them currently recruiting, and 236 completed. 30 of these trials are in Phase 3-4 (later-stage) and 80 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Multiple Sclerosis, with 10 trials.
Top-decile sponsor footprint
University of Illinois at Chicago ranks in the top decile of sponsors by registered trial count (#83 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
236 of 271 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (87.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
430 total, page 8 of 9
Mindfulness Intervention to Study the Neurobiology of Depression
NCT01905267
BAILA: Being Active, Increasing Latinos Healthy Aging
NCT01988233
Safety and Efficacy Study of Dronabinol to Treat Obstructive Sleep Apnea
NCT01755091
Fit and Strong! Plus Comparative Effectiveness Trial
NCT03180008
Home Exercise Intervention in Persons With Multiple Sclerosis
NCT01824550
Treatment Outcomes in Patient With Nontuberculous Mycobacterial Disease
NCT01680822
Partially HLA Mismatched (Haploidentical) Allogeneic Bone Marrow Transplantation
NCT01749293
Young Adult Smoker's Treatment Demand
NCT01569529
Culturally Targeted & Individually Tailored Smoking Cessation Study: LGBT Smokers
NCT01633567
Health Promoters and Pharmacists in Diabetes Team Management
NCT01498159
Long-term Effects of Dutasteride on Architectural and Nuclear Morphometric Features of Benign Prostate Tissue
NCT01473030
Validation of Digital Morphometry for Cancer Risk in Benign Prostate Biopsies
NCT01594502
Comparative Effectiveness Research to Enhance Outcomes in African-Americans With Obstructive Sleep Apnea
NCT01997723
Association Between Vitamin D and Inflammation and Diabetes Risk in Morbidly Obese Pre-Menopausal Women
NCT02169050
The Incidence of Perioperative Deep Venous Thromboses of the Lower Extremities
NCT01300832
Male Circumcision Services for HIV Prevention in the Dominican Republic
NCT02337179
Alternate Day Fasting for Weight Loss, Weight Maintenance and Cardio-protection
NCT00960505
20089 TA+Lucentis Combo Intravitreal Injections for Treatment of Neovascular Age-related Macular Degeneration (AMD)
NCT01175395
Study to Education Childhood Cancer Survivors About Survivorship Care
NCT01742481
PHAT Life: Preventing HIV/AIDS Among Teens in Juvenile Justice
NCT02647710
Consultation in the Emergency Department
NCT01316172
Sodium Channel Splicing in Heart Failure Trial
NCT01185587
Effects of Carrageenan-Elimination Diet on Ulcerative Colitis Disease Activity
NCT01065571
Identification of Markers for Determining the Efficacy of Vitamin D Receptor Activator Therapy in Stage 3/4 CKD Patients
NCT02018133
Research Investigation of Soy and Estrogen
NCT00997893
Medication Adherence in Schizophrenia: Development of a CBT-Based Intervention
NCT00980252
Myelin, Glia and Depression in Type 2 Diabetes
NCT01327404
Cortical/Subcortical Circuits in Late-Life Depression
NCT01327417
Intensity Modulated Total Marrow Irradiation (IM-TMI) for Advanced Hematologic Malignancies
NCT00988013
Internet-based HIV/STI Prevention for Young MSM Receiving HIV Testing
NCT00968188
Intensive Nutrition in Acute Respiratory Distress Syndrome (ARDS): A Clinical Trial (INTACT)
NCT01921101
Oculomotor and Spatial Cognition Deficits in Schizophrenia
NCT00931996
Nurse Managed Sequential Strength Training and Bicycle Training in Chronic Obstructive Pulmonary Disease (COPD)
NCT01058213
Motor Training for Fall Prevention
NCT01621958
Study of Bicycle Seat Effects on Male Perineal Blood Flow
NCT01804725
Vertebrobasilar Flow Evaluation and Risk of Transient Ischemic Attack and Stroke (VERiTAS)
NCT00590980
Measuring Quality of Medical Student Performance at Contextualizing Care
NCT01088438
Cognitive Behavioral Therapy for Insomnia in People With Chronic Obstructive Pulmonary Disease(COPD)
NCT01072292
Efficacy of Vitamin D in Colorectal Cancer Chemoprevention
NCT01574027
The Assessment of Oxidative Stress Markers and the Development of Atrial Fibrillation After Cardiac Surgery
NCT00846534
Chewed vs. Crushed Lanthanum Carbonate in Hemodialysis Patients
NCT00660530
Randomized Controlled Trial of Wellness Recovery Action Planning
NCT01024569
Teleconference Fatigue Management for People With Multiple Sclerosis
NCT00591721
Design & Evaluation of a Medication Therapy Management Program to Improve Patient Safety in Medicare Beneficiaries
NCT00773942
The Effect of Exercise on Individuals With Parkinson's Disease
NCT00591344
Use of Simvastatin for the Prevention of Vasospasm in Aneurysmal Subarachnoid Hemorrhage
NCT00487461
Effectiveness of a Computerized Tool (PAINRelieveIt) to Help Manage Pain Related to Sickle Cell Disease
NCT00600665
Adherence Dynamics for Whole Food Interventions in African-American Men
NCT01408459
Feeding and Transition to Home for Preterms at Social Risk
NCT02041923
Efficacy of Phosphate Binding in Healthy Volunteers: Chewed Versus Crushed Lanthanum Carbonate
NCT00458289
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 37 |
| Phase 2 | 43 |
| Phase 3 | 11 |
| Phase 4 | 19 |
Therapeutic Areas
What is open in the University of Illinois at Chicago pipeline
115 recruiting of 430 indexed (27% open); 236 completed (55%).
Phase mix: 30 late (III/IV) vs 80 early (I/II) (early-phase heavy).
Top condition: Multiple Sclerosis (10 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Illinois at Chicago: open-pipeline peers nationwide
Peers matched on 430 registered trials and 27% open enrollment, not the therapeutic-area sidebar.
University of Illinois at Chicago sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 430 trials (± recruiting share)
- Vanderbilt University · 430 trials · 3% recruiting
- Children's Hospital of Philadelphia · 431 trials · 18% recruiting
- Novo Nordisk A/S · 431 trials · 8% recruiting
- Dartmouth-Hitchcock Medical Center · 427 trials · 12% recruiting
Sponsors near 27% open enrollment (± trial volume)
- Coherus Oncology · 27% recruiting · 15 trials
- NewAmsterdam Pharma · 27% recruiting · 15 trials
- Portland VA Medical Center · 27% recruiting · 15 trials
- White River Junction Veterans Affairs Medical Center · 27% recruiting · 15 trials
Related
What to do with this University of Illinois at Chicago page
430 registered trials is a research-attention snapshot, not an endorsement of University of Illinois at Chicago or any single study.
- 115 of University of Illinois at Chicago's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Multiple Sclerosis is the condition University of Illinois at Chicago studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Multiple Sclerosis trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Illinois at Chicago pipeline card: 430 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.